ABIVAX Société Anonyme (EPA:ABVX)
France flag France · Delayed Price · Currency is EUR
96.60
-4.40 (-4.36%)
At close: Jan 28, 2026

ABIVAX Société Anonyme Revenue

ABIVAX Société Anonyme had revenue of 639.00K EUR in the quarter ending September 30, 2025, a decrease of -88.61%. This brings the company's revenue in the last twelve months to 5.31M, down -42.89% year-over-year. In the year 2024, ABIVAX Société Anonyme had annual revenue of 10.79M with 135.94% growth.

Revenue (ttm)
5.31M
Revenue Growth
-42.89%
P/S Ratio
1,415.63
Revenue / Employee
79.27K
Employees
67
Market Cap
7.52B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202410.79M6.22M135.94%
Dec 31, 20234.57M69.00K1.53%
Dec 31, 20224.51M302.00K7.19%
Dec 31, 20214.20M4.19M29,921.43%
Dec 31, 202014.00K21.00K-
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE179.91M
Cellectis70.36M
Genfit45.13M
MedinCell32.44M
Inventiva16.97M
Adocia12.88M
Innate Pharma12.64M
Nanobiotix10.16M
Revenue Rankings